Personal tools

Coexpression cluster:C98

From FANTOM5_SSTAR

Revision as of 15:06, 13 July 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C98_CD8_Natural_Basophils_blood_CD4_Peripheral_Whole



Phase1 CAGE Peaks

Hg19::chr10:72360327..72360336,-p6@PRF1
Hg19::chr10:72362460..72362475,-p1@PRF1
Hg19::chr11:108094520..108094540,+p@chr11:108094520..108094540
+
Hg19::chr11:108094553..108094560,+p@chr11:108094553..108094560
+
Hg19::chr11:122709344..122709378,+p@chr11:122709344..122709378
+
Hg19::chr11:128498871..128498879,+p@chr11:128498871..128498879
+
Hg19::chr12:10460438..10460485,+p1@KLRD1
Hg19::chr12:10460489..10460500,+p3@KLRD1
Hg19::chr12:10460570..10460585,+p2@KLRD1
Hg19::chr12:10461953..10461958,+p4@KLRD1
Hg19::chr12:10476477..10476481,+p@chr12:10476477..10476481
+
Hg19::chr12:10542623..10542647,-p1@KLRK1
Hg19::chr12:10542654..10542666,-p3@KLRK1
Hg19::chr12:10561626..10561641,-p@chr12:10561626..10561641
-
Hg19::chr12:10562135..10562149,-p1@ENST00000539300
p1@ENST00000539370
Hg19::chr12:10563996..10564002,-p@chr12:10563996..10564002
-
Hg19::chr12:10564247..10564267,-p@chr12:10564247..10564267
-
Hg19::chr12:10705960..10705966,+p1@ENST00000544591
Hg19::chr12:10752214..10752231,-p1@ENST00000521068
Hg19::chr12:47759534..47759544,-p@chr12:47759534..47759544
-
Hg19::chr12:6884167..6884181,+p4@LAG3
Hg19::chr12:6884195..6884206,+p5@LAG3
Hg19::chr12:9144740..9144749,+p11@KLRG1
Hg19::chr12:9144787..9144796,+p10@KLRG1
Hg19::chr12:9760499..9760520,-p1@KLRB1
Hg19::chr12:9980007..9980012,+p5@KLRF1
Hg19::chr12:9980015..9980039,+p2@KLRF1
Hg19::chr12:9980051..9980062,+p4@KLRF1
Hg19::chr12:9980069..9980087,+p1@KLRF1
Hg19::chr12:9980113..9980133,+p3@KLRF1
Hg19::chr14:102290125..102290135,+p13@PPP2R5C
Hg19::chr14:25078866..25078900,-p1@GZMH
Hg19::chr14:25078915..25078944,-p2@GZMH
Hg19::chr14:25078961..25078977,-p3@GZMH
Hg19::chr14:52734401..52734446,+p1@PTGDR
Hg19::chr14:91866533..91866544,-p@chr14:91866533..91866544
-
Hg19::chr14:98172466..98172486,+p@chr14:98172466..98172486
+
Hg19::chr14:98172510..98172521,+p@chr14:98172510..98172521
+
Hg19::chr14:98680322..98680334,+p@chr14:98680322..98680334
+
Hg19::chr14:99753684..99753709,-p@chr14:99753684..99753709
-
Hg19::chr15:29211622..29211634,+p9@APBA2
Hg19::chr15:44968000..44968011,-p7@PATL2
Hg19::chr15:44969063..44969079,-p3@PATL2
Hg19::chr15:44969086..44969121,-p2@PATL2
Hg19::chr15:86236385..86236399,+p21@AKAP13
Hg19::chr16:2891972..2891987,-p1@PRSS30P
Hg19::chr16:2892006..2892017,-p2@PRSS30P
Hg19::chr16:405223..405242,-p@chr16:405223..405242
-
Hg19::chr16:405262..405285,-p@chr16:405262..405285
-
Hg19::chr16:53479662..53479672,+p13@RBL2
Hg19::chr16:53479673..53479710,+p3@RBL2
Hg19::chr16:53484007..53484046,+p7@RBL2
Hg19::chr16:57626673..57626679,-p@chr16:57626673..57626679
-
Hg19::chr16:88769979..88770008,-p2@RNF166
Hg19::chr16:88770052..88770065,-p4@RNF166
Hg19::chr16:89789248..89789270,+p8@ZNF276
Hg19::chr16:89789271..89789291,+p5@ZNF276
Hg19::chr17:33814824..33814834,-p7@SLFN12L
Hg19::chr17:33815324..33815342,-p6@SLFN12L
Hg19::chr17:34430980..34430984,+p3@CCL4
Hg19::chr17:34431082..34431115,+p4@CCL4
Hg19::chr17:34476414..34476434,-p@chr17:34476414..34476434
-
Hg19::chr17:37865861..37865878,+p@chr17:37865861..37865878
+
Hg19::chr17:61517622..61517633,-p@chr17:61517622..61517633
-
Hg19::chr17:75431450..75431461,-p@chr17:75431450..75431461
-
Hg19::chr17:78682519..78682561,+p@chr17:78682519..78682561
+
Hg19::chr17:80275399..80275416,-p3@CD7
Hg19::chr19:10628117..10628130,-p1@S1PR5
Hg19::chr19:10908560..10908583,+p@chr19:10908560..10908583
+
Hg19::chr19:30101122..30101134,+p@chr19:30101122..30101134
+
Hg19::chr19:4917016..4917055,-p2@AK097879
Hg19::chr19:51875274..51875286,-p@chr19:51875274..51875286
-
Hg19::chr19:51875861..51875872,-p2@NKG7
Hg19::chr19:51875894..51875975,-p1@NKG7
Hg19::chr19:544039..544065,+p1@GZMM
Hg19::chr1:117349021..117349041,-p@chr1:117349021..117349041
-
Hg19::chr1:145715572..145715599,-p1@CD160
Hg19::chr1:145715634..145715642,-p2@CD160
Hg19::chr1:157670658..157670667,-p4@FCRL3
Hg19::chr1:157670670..157670684,-p5@FCRL3
Hg19::chr1:159770292..159770315,+p1@FCRL6
Hg19::chr1:159772121..159772159,+p2@FCRL6
Hg19::chr1:202172827..202172845,+p5@LGR6
Hg19::chr1:202172848..202172894,+p2@LGR6
Hg19::chr1:26697182..26697187,-p5@ZNF683
Hg19::chr1:26697189..26697205,-p2@ZNF683
Hg19::chr1:26697243..26697258,-p1@ZNF683
Hg19::chr1:41771607..41771618,-p@chr1:41771607..41771618
-
Hg19::chr1:8986862..8986905,-p@chr1:8986862..8986905
-
Hg19::chr1:8986930..8986955,-p@chr1:8986930..8986955
-
Hg19::chr1:90075464..90075470,-p@chr1:90075464..90075470
-
Hg19::chr1:9777652..9777678,-p@chr1:9777652..9777678
-
Hg19::chr1:9777710..9777721,-p@chr1:9777710..9777721
-
Hg19::chr20:57757940..57757966,+p1@ZNF831
Hg19::chr21:47844888..47844896,+p@chr21:47844888..47844896
+
Hg19::chr22:23101972..23101984,-p@chr22:23101972..23101984
-
Hg19::chr22:23161491..23161502,+p2@IGLV3-9
Hg19::chr22:23163296..23163300,-p@chr22:23163296..23163300
-
Hg19::chr22:37627503..37627591,-p6@RAC2
Hg19::chr22:37627612..37627625,-p18@RAC2
Hg19::chr22:46677407..46677438,+p@chr22:46677407..46677438
+
Hg19::chr22:46677442..46677447,+p@chr22:46677442..46677447
+
Hg19::chr22:46685694..46685729,+p@chr22:46685694..46685729
+
Hg19::chr2:107103805..107103824,+p1@ENST00000303432
p1@ENST00000446559
Hg19::chr2:107103861..107103870,+p1@ENST00000417670
Hg19::chr2:182038499..182038509,+p@chr2:182038499..182038509
+
Hg19::chr2:37827039..37827047,+p1@ENST00000419425
Hg19::chr2:37827073..37827104,+p3@ENST00000419425
Hg19::chr2:38830433..38830444,-p10@HNRPLL
Hg19::chr2:43359692..43359706,-p@chr2:43359692..43359706
-
Hg19::chr2:8422694..8422702,-p@chr2:8422694..8422702
-
Hg19::chr2:85921998..85922016,+p8@GNLY
Hg19::chr2:85922031..85922057,+p5@GNLY
Hg19::chr2:87012395..87012400,-p@chr2:87012395..87012400
-
Hg19::chr2:87053149..87053161,-p@chr2:87053149..87053161
-
Hg19::chr2:87053183..87053198,-p@chr2:87053183..87053198
-
Hg19::chr2:87053245..87053263,-p@chr2:87053245..87053263
-
Hg19::chr2:87053274..87053287,-p@chr2:87053274..87053287
-
Hg19::chr2:87053288..87053295,-p@chr2:87053288..87053295
-
Hg19::chr2:87053338..87053349,-p@chr2:87053338..87053349
-
Hg19::chr2:98330258..98330297,+p@chr2:98330258..98330297
+
Hg19::chr2:99278536..99278548,-p@chr2:99278536..99278548
-
Hg19::chr2:99278552..99278568,-p@chr2:99278552..99278568
-
Hg19::chr2:99279928..99279942,-p2@MGAT4A
Hg19::chr2:99279946..99279957,-p4@MGAT4A
Hg19::chr2:99279996..99280007,-p6@MGAT4A
Hg19::chr2:99280024..99280037,-p3@MGAT4A
Hg19::chr3:15345817..15345834,-p@chr3:15345817..15345834
-
Hg19::chr3:15345839..15345879,-p@chr3:15345839..15345879
-
Hg19::chr3:15345887..15345911,-p@chr3:15345887..15345911
-
Hg19::chr3:188839075..188839104,+p5@TPRG1
Hg19::chr3:27754397..27754419,+p@chr3:27754397..27754419
+
Hg19::chr3:27763151..27763173,-p@chr3:27763151..27763173
-
Hg19::chr3:27763807..27763822,-p1@EOMES
Hg19::chr3:28333250..28333259,+p5@CMC1
Hg19::chr3:28333332..28333352,+p2@CMC1
Hg19::chr3:39273990..39274028,+p@chr3:39273990..39274028
+
Hg19::chr3:50378363..50378383,-p10@RASSF1
Hg19::chr3:50378388..50378410,-p5@RASSF1
Hg19::chr4:103536099..103536131,-p@chr4:103536099..103536131
-
Hg19::chr4:103551892..103551903,-p@chr4:103551892..103551903
-
Hg19::chr4:122104714..122104718,-p@chr4:122104714..122104718
-
Hg19::chr4:148973904..148973919,+p@chr4:148973904..148973919
+
Hg19::chr4:153022203..153022216,+p1@ENST00000499452
p1@uc003imp.1
Hg19::chr4:4271326..4271347,-p@chr4:4271326..4271347
-
Hg19::chr4:4271366..4271377,-p@chr4:4271366..4271377
-
Hg19::chr4:48116477..48116487,-p4@TXK
Hg19::chr4:48116540..48116569,-p2@TXK
Hg19::chr5:35780579..35780585,+p@chr5:35780579..35780585
+
Hg19::chr5:35822699..35822708,-p@chr5:35822699..35822708
-
Hg19::chr5:35856882..35856909,-p@chr5:35856882..35856909
-
Hg19::chr5:35857894..35857919,+p@chr5:35857894..35857919
+
Hg19::chr5:35859218..35859252,-p@chr5:35859218..35859252
-
Hg19::chr5:39203244..39203272,+p@chr5:39203244..39203272
+
Hg19::chr5:54320078..54320090,+p1@GZMK
Hg19::chr6:108053352..108053354,-p3@SCML4
Hg19::chr6:112081113..112081154,-p4@FYN
Hg19::chr6:112115074..112115094,-p3@FYN
Hg19::chr6:112115103..112115122,-p10@FYN
Hg19::chr6:112115138..112115155,-p6@FYN
Hg19::chr6:112115162..112115173,-p20@FYN
Hg19::chr6:128239704..128239722,-p4@THEMIS
Hg19::chr6:128239732..128239745,-p2@THEMIS
Hg19::chr6:128239749..128239760,-p6@THEMIS
Hg19::chr6:128299606..128299618,+p@chr6:128299606..128299618
+
Hg19::chr6:130536707..130536763,-p2@SAMD3
Hg19::chr6:35569582..35569593,-p@chr6:35569582..35569593
-
Hg19::chr6:35570546..35570560,-p@chr6:35570546..35570560
-
Hg19::chr7:142202124..142202131,-p@chr7:142202124..142202131
-
Hg19::chr7:142496418..142496422,+p@chr7:142496418..142496422
+
Hg19::chr7:150148709..150148722,+p@chr7:150148709..150148722
+
Hg19::chr7:3157659..3157673,-p@chr7:3157659..3157673
-
Hg19::chr7:36763796..36763808,-p5@AOAH
Hg19::chr7:36763824..36763825,-p10@AOAH
Hg19::chr7:36763827..36763849,-p3@AOAH
Hg19::chr7:38339870..38339884,-p1@uc003tgl.1
Hg19::chr7:38339890..38339930,-p1@TRGV10
Hg19::chr7:38339942..38339971,-p2@TRGV10
Hg19::chr7:38370096..38370108,-p1@X06776
Hg19::chr7:38370567..38370591,-p1@uc010kxj.1
Hg19::chr7:38370595..38370606,-p2@uc010kxj.1
Hg19::chr7:38394132..38394135,-p2@TRGV4
Hg19::chr8:1806877..1806888,+p4@ARHGEF10
Hg19::chr8:1806935..1806947,+p3@ARHGEF10
Hg19::chr9:130482517..130482528,+p2@TTC16
Hg19::chr9:130482537..130482559,+p1@TTC16
Hg19::chr9:130668851..130668877,-p@chr9:130668851..130668877
-
Hg19::chr9:136006379..136006394,-p20@RALGDS
Hg19::chr9:136006566..136006581,-p11@RALGDS
Hg19::chr9:98257510..98257517,-p@chr9:98257510..98257517
-
Hg19::chrX:153579541..153579552,-p90@FLNA


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

p.valueFDRnGenesnPathwayName
3.80749961374406e-060.002410147255499995137Natural killer cell mediated cytotoxicity (KEGG):04650
0.0002607991592174420.0323074216336034372Viral myocarditis (KEGG):05416
0.0003062314846787050.03230742163360344188Focal Adhesion (Wikipathways):WP306
8.11025802005085e-050.0256689666334614133T Cell Receptor Signaling Pathway (Wikipathways):WP69
0.0004106868679187090.0371378267703633384DNA damage response (only ATM dependent) (Wikipathways):WP710
0.0002326727773878030.03230742163360346511Signaling in Immune system (Reactome):REACT_6900
0.000130285429575460.027490225640422357IL-7 up reg. targets (Netpath):NetPath_19
0.0005936458987092410.0469722317353687221{HRAS,27} (Static Module):NA



Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0006952defense response3.15920037879371e-06
GO:0007165signal transduction3.15920037879371e-06
GO:0006968cellular defense response3.15920037879371e-06
GO:0007154cell communication1.80819303646231e-05
GO:0019835cytolysis7.27155456952761e-05
GO:0001906cell killing7.35227439784253e-05
GO:0007166cell surface receptor linked signal transduction0.000748162774117999
GO:0001912positive regulation of leukocyte mediated cytotoxicity0.00100087214500488
GO:0045954positive regulation of natural killer cell mediated cytotoxicity0.00100087214500488
GO:0042269regulation of natural killer cell mediated cytotoxicity0.00126018343181031
GO:0004871signal transducer activity0.00138870150259774
GO:0060089molecular transducer activity0.00138870150259774
GO:0005529sugar binding0.00168697079771395
GO:0031341regulation of cell killing0.00179634483162779
GO:0001910regulation of leukocyte mediated cytotoxicity0.00179634483162779
GO:0002228natural killer cell mediated immunity0.00193582871108738
GO:0042267natural killer cell mediated cytotoxicity0.00193582871108738
GO:0001909leukocyte mediated cytotoxicity0.00301839651130556
GO:0030246carbohydrate binding0.00517328494193105
GO:0032502developmental process0.00592166323900008
GO:0042287MHC protein binding0.00714615676614147
GO:0004872receptor activity0.0111125372061156
GO:0002429immune response-activating cell surface receptor signaling pathway0.0111616425003951
GO:0002768immune response-regulating cell surface receptor signaling pathway0.0112420450095393
GO:0002757immune response-activating signal transduction0.0112420450095393
GO:0032393MHC class I receptor activity0.0112420450095393
GO:0002764immune response-regulating signal transduction0.0115157528199679
GO:0046649lymphocyte activation0.0126404207531485
GO:0005886plasma membrane0.0136008522554332
GO:0004715non-membrane spanning protein tyrosine kinase activity0.0152332451505962
GO:0050528acyloxyacyl hydrolase activity0.0160270083928854
GO:0002223stimulatory C-type lectin receptor signaling pathway0.0160270083928854
GO:0032394MHC class Ib receptor activity0.0160270083928854
GO:0045321leukocyte activation0.0160270083928854
GO:0009897external side of plasma membrane0.0203583098090236
GO:0001775cell activation0.0231316833403306
GO:0004888transmembrane receptor activity0.0231316833403306
GO:0019992diacylglycerol binding0.0248220893604138
GO:0002220innate immune response activating cell surface receptor signaling pathway0.0248220893604138
GO:0001785prostaglandin J receptor activity0.0248220893604138
GO:0004956prostaglandin D receptor activity0.0248220893604138
GO:0002253activation of immune response0.0248220893604138
GO:0007264small GTPase mediated signal transduction0.0248220893604138
GO:0002449lymphocyte mediated immunity0.0248220893604138
GO:0006927transformed cell apoptosis0.0248220893604138
GO:0052185modification of structure of other organism during symbiotic interaction0.0248220893604138
GO:0051818disruption of cells of other organism during symbiotic interaction0.0248220893604138
GO:0051883killing of cells in other organism during symbiotic interaction0.0248220893604138
GO:0044004disruption by symbiont of host cells0.0248220893604138
GO:0051817modification of morphology or physiology of other organism during symbiotic interaction0.0248220893604138
GO:0051715cytolysis of cells of another organism0.0248220893604138
GO:0052332modification by organism of cell membrane in other organism during symbiotic interaction0.0248220893604138
GO:0052111modification by symbiont of host structure0.0248220893604138
GO:0008454alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity0.0248220893604138
GO:0052331hemolysis by organism of red blood cells in other organism during symbiotic interaction0.0248220893604138
GO:0019836hemolysis by symbiont of host red blood cells0.0248220893604138
GO:0052025modification by symbiont of host cell membrane0.0248220893604138
GO:0051801cytolysis of cells in other organism during symbiotic interaction0.0248220893604138
GO:0045085negative regulation of interleukin-2 biosynthetic process0.0248220893604138
GO:0001907killing by symbiont of host cells0.0248220893604138
GO:0052043modification by symbiont of host cellular component0.0248220893604138
GO:0031640killing of cells of another organism0.0248220893604138
GO:0001897cytolysis by symbiont of host cells0.0248220893604138
GO:0044003modification by symbiont of host morphology or physiology0.0248220893604138
GO:0052188modification of cellular component in other organism during symbiotic interaction0.0248220893604138
GO:0002443leukocyte mediated immunity0.0252276812096993
GO:0016265death0.0252276812096993
GO:0008219cell death0.0252276812096993
GO:0051239regulation of multicellular organismal process0.0268161173699717
GO:0031226intrinsic to plasma membrane0.0272631429682332
GO:0050778positive regulation of immune response0.0282900651600007
GO:0002684positive regulation of immune system process0.0282900651600007
GO:0006954inflammatory response0.0282900651600007
GO:0042221response to chemical stimulus0.0282900651600007
GO:0042289MHC class II protein binding0.0282900651600007
GO:0006926virus-infected cell apoptosis0.0282900651600007
GO:0007610behavior0.0283669156309477
GO:0004713protein-tyrosine kinase activity0.0315735187959461
GO:0005085guanyl-nucleotide exchange factor activity0.0316006328384633
GO:0042110T cell activation0.0316006328384633
GO:0050776regulation of immune response0.0316006328384633
GO:0032729positive regulation of interferon-gamma production0.0316006328384633
GO:0002218activation of innate immune response0.0316006328384633
GO:0002758innate immune response-activating signal transduction0.0316006328384633
GO:0030238male sex determination0.0316006328384633
GO:0009605response to external stimulus0.0319202106836106
GO:0002682regulation of immune system process0.0319202106836106
GO:0007242intracellular signaling cascade0.0334959429843757
GO:0031224intrinsic to membrane0.0334959429843757
GO:0051240positive regulation of multicellular organismal process0.0334959429843757
GO:0051704multi-organism process0.0334959429843757
GO:0004252serine-type endopeptidase activity0.0334959429843757
GO:0004465lipoprotein lipase activity0.0342708827623643
GO:0032649regulation of interferon-gamma production0.0342708827623643
GO:0048518positive regulation of biological process0.0347828901366737
GO:0002252immune effector process0.0347828901366737
GO:0050789regulation of biological process0.0349508232004269
GO:0001816cytokine production0.0358879717932517
GO:0045087innate immune response0.0361337974734535
GO:0043550regulation of lipid kinase activity0.0375627317055293
GO:0042993positive regulation of transcription factor import into nucleus0.0400389946836785
GO:0045429positive regulation of nitric oxide biosynthetic process0.0400389946836785
GO:0006491N-glycan processing0.0400389946836785
GO:0042307positive regulation of protein import into nucleus0.0400389946836785
GO:0004691cAMP-dependent protein kinase activity0.0400389946836785
GO:0045471response to ethanol0.0400389946836785
GO:0008236serine-type peptidase activity0.0400389946836785
GO:0017171serine hydrolase activity0.0400389946836785
GO:0005515protein binding0.0401205382710156
GO:0031348negative regulation of defense response0.0434603528758918
GO:0050728negative regulation of inflammatory response0.0434603528758918
GO:0006955immune response0.0461820368963266
GO:0046824positive regulation of nucleocytoplasmic transport0.0461820368963266
GO:0045428regulation of nitric oxide biosynthetic process0.0461820368963266
GO:0004960thromboxane receptor activity0.0461820368963266
GO:0045089positive regulation of innate immune response0.0461820368963266
GO:0042330taxis0.0474244108887489
GO:0006935chemotaxis0.0474244108887489
GO:0050868negative regulation of T cell activation0.0479396864995311
GO:0045088regulation of innate immune response0.0479396864995311
GO:0051222positive regulation of protein transport0.0479396864995311
GO:0009986cell surface0.0479396864995311
GO:0009611response to wounding0.0479396864995311
GO:0009966regulation of signal transduction0.0491226070247582
GO:0005089Rho guanyl-nucleotide exchange factor activity0.0491226070247582
GO:0007265Ras protein signal transduction0.0491226070247582
GO:0048468cell development0.0491226070247582
GO:0004690cyclic nucleotide-dependent protein kinase activity0.0497779998182119
GO:0050832defense response to fungus0.0497779998182119



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen
hematopoietic stem cell1.14e-49172
angioblastic mesenchymal cell1.14e-49172
leukocyte4.42e-46140
hematopoietic oligopotent progenitor cell7.63e-46165
hematopoietic multipotent progenitor cell7.63e-46165
hematopoietic cell4.71e-44182
nongranular leukocyte1.13e-37119
hematopoietic lineage restricted progenitor cell6.00e-37124
myeloid cell6.64e-23112
common myeloid progenitor6.64e-23112
lymphoid lineage restricted progenitor cell5.89e-2252
lymphocyte6.59e-2253
common lymphoid progenitor6.59e-2253
myeloid leukocyte3.20e-1976
granulocyte monocyte progenitor cell9.41e-1671
myeloid lineage restricted progenitor cell2.67e-1570
T cell4.38e-1525
pro-T cell4.38e-1525
macrophage dendritic cell progenitor2.74e-1465
monopoietic cell3.14e-1463
monocyte3.14e-1463
monoblast3.14e-1463
promonocyte3.14e-1463
CD14-positive, CD16-negative classical monocyte3.51e-1442
classical monocyte4.93e-1345
mature alpha-beta T cell7.39e-1318
alpha-beta T cell7.39e-1318
immature T cell7.39e-1318
mature T cell7.39e-1318
immature alpha-beta T cell7.39e-1318
CD8-positive, alpha-beta T cell6.18e-0911
lymphocyte of B lineage5.32e-0724
pro-B cell5.32e-0724
Uber Anatomy
Ontology termp-valuen
adult organism6.29e-28115
hematopoietic system1.59e-20102
blood island1.59e-20102
hemolymphoid system6.32e-18112
immune system5.02e-12115
bone marrow2.52e-1180
bone element3.45e-1086
blood1.00e-0815
haemolymphatic fluid1.00e-0815
organism substance1.00e-0815
skeletal element2.64e-07101
skeletal system2.64e-07101
Disease
Ontology termp-valuen
hematologic cancer4.25e-0751
immune system cancer4.25e-0751


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C98&oldid=1851581"